Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $35.9800 (1.12%) ($35.9800 - $35.9800) on Wed. Mar. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.8% (three month average) | RSI | 52 | Latest Price | $35.9800(1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.3% a day on average for past five trading days. | Weekly Trend | HALO advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(45%) IWM(44%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.4% in a week (0% probabilities). VIXM(-24%) UUP(-11%) VXX(-8%) TBT(-3%) GLD(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.4% (StdDev 2.8%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.58(1.12%) | 10 Day Moving Average | $34.52(4.23%) | 20 Day Moving Average | $34.47(4.38%) | To recent high | -12.3% | To recent low | 13.1% | Market Cap | $4.917b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |